At a recent morning clinical conference, Dr. Seth Marcus provided a terrific update on eosinophilic esophagitis (EoE). I am placing some of the slides below and the following is a link to the full lecture: The Evolution of EoE -Seth Marcus
During this part of the presentation, there was a discussion regarding the role of allergists. Due to the poor predictive value (negative and positive) of allergy testing (skin tests and blood tests), the consensus is that routine allergy evaluation is NOT needed for children with EoE. However, IgE-mediated food allergies along with other atopic diseases are common in children with EoE and selected patients could benefit from allergy referral.
The slide above reviews the main treatment options: topical corticosteroids, proton pump inhibitor therapy, and elimination diet. While all of these are reasonable as first-line approaches, many in the group favored proton pump inhibitor (PPI) treatment as initial therapy. In those with a very good response (<5 eos/hpf at followup), this would allow lower dose PPI as a maintenance option. Another point of discussion was the fact that PPI responders tend to more favorably metabolize the PPIs to achieve higher therapeutic levels. It is anticipated that future treatment could be influenced by knowing the individual’s CYP2C19*17 Polymporphisms (#NASPGHAN17 EoE Session)
Related blog posts:
- Long-term Use of PPIs for EoE
- Do we still need PPI-REE?
- Nexium versus Fluticasone for EoE
- Guidelines for Eosinophilic Esophagitis
- Higher Doses of Topical Steroids for Eosinophilic Esophagitis …
- Putting in Place a Big Piece of the Eosinophilic Esophagitis …
- Eosinophilic Esophagitis Slide Set | gutsandgrowth
- MicroRNA signature for eosinophilic esophagitis | gutsandgrowth
- EoE: Drugs, Diets, Dilatation and PPI-REE
Pingback: Negligible Effect of Eosinophilic Esophagitis Treatment on Longitudinal Growth | gutsandgrowth
Pingback: Promising Biologic for Eosinophilic Esophagitis | gutsandgrowth
Pingback: What Happens When Topical Steroids Are Stopped in Eosinophilic Esophagitis | gutsandgrowth
Pingback: Highest Reported Prevalence Rates for Eosinophilic Esophagits | gutsandgrowth
Pingback: Best Approach for Identifying Eosinophilic Esophagitis | gutsandgrowth
Pingback: Orodispensable Budesonide Tablets for Eosinophilic Esophagitis | gutsandgrowth
Pingback: Head-to-Head: Budesonide vs Fluticasone for Eosinophilic Esophagitis | gutsandgrowth
Pingback: EoP –Biomarker or Balderdash? | gutsandgrowth
Pingback: Georgia AAP Nutrition Symposium 2019: Food Allergy Immunotherapy | gutsandgrowth
Pingback: Grading Treatment Response in Eosinophilic Esophagitis | gutsandgrowth
Pingback: Most Popular Posts of 2019 | gutsandgrowth
Pingback: New Therapy for Eosinophilic Esophagitis | gutsandgrowth
Pingback: Could Immunotherapy (EPIT) Work For Eosinophilic Esophagitis? & Coronavirus Up-to-Date Tally | gutsandgrowth
Pingback: New 2020 Eosinophilic Esophagitis Guidelines | gutsandgrowth
Pingback: Eosinophilic Esophagitis -Up to Date Dietary Management Review | gutsandgrowth
Pingback: Phase 3 Trial of Budesonide for Eosinophilic Esophagitis & COVID-19 Deaths in U.S. | gutsandgrowth
Pingback: Lingering Histologic Changes with Eosinophilic Esophagitis in Remission, Plus One | gutsandgrowth
Pingback: How Effective Are PPIs for Eosinophilic Esophagitis? | gutsandgrowth
Pingback: Eosinophilic Esophagitis -FAQs | gutsandgrowth
Pingback: Expecting Change in Eosinophilic Esophagitis Treatment | gutsandgrowth
Pingback: More “LIGHT” in Understanding Eosinophilic Esophagitis | gutsandgrowth
Pingback: Interleukin-13 Monoclonal Antibody for Eosinophilic Esophagitis & More COVID-19 Data | gutsandgrowth
Pingback: Frequency of Strictures in Pediatric Eosinophilic Esophagitis | gutsandgrowth
Pingback: Genetic Basis of Eosinophilic Esophagitis | gutsandgrowth
Pingback: Maintenance Topical Steroid Dosing for Eosinophilic Esophagitis | gutsandgrowth